21 October 2017
News and Views
Links and Services
This week's issue of the New England Journal of Medicine investigates the use of sofosbuvir for Hepatitis C genotype 2 or 3 in patients without treatment options.
Patients chronically infected with hepatitis C virus (HCV) genotype 2 or 3 for whom treatment wit
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors